Newsletter - November 30, 2017
No, FDA Did Not Change Stem Cell Regulations As Advertised
The week before Thanksgiving, FDA announced “a comprehensive regenerative medicine policy framework” with great fanfare and it appeared that it is finally going to make significant changes to its policies for regulating stem cells. But a review of this framework shows that it is mostly a rehash of old statements and policies. Read More
Widely Available Supplements Contain Unapproved Drugs
Dietary supplements are frequently found to have major quality issues so this should not come as a surprise that another formal study found that about half the products did not contain the active ingredient on the label, about 40% contained other unapproved drugs, about 1 in four products contained products not listed on the label.... Read More
No, FDA Did Not Change Stem Cell Regulations As Advertised
The week before Thanksgiving, FDA announced “a comprehensive regenerative medicine policy framework” with great fanfare and it appeared that it is finally going to make significant changes to its policies for regulating stem cells. But a review of this framework shows that it is mostly a rehash of old statements and policies. Read More
Widely Available Supplements Contain Unapproved Drugs
Dietary supplements are frequently found to have major quality issues so this should not come as a surprise that another formal study found that about half the products did not contain the active ingredient on the label, about 40% contained other unapproved drugs, about 1 in four products contained products not listed on the label.... Read More
